Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116375653A details a high enantioselective iridium-catalyzed method for chiral tetrahydroquinazoline derivatives, offering cost-effective API intermediate manufacturing solutions.
Patent CN112920173A details a mild, high-yield synthesis of chiral chromans with potent anticancer activity, offering reliable supply chain solutions.
Patent CN111423351A discloses a novel chiral copper complex for asymmetric Mukaiyama Aldol reactions, offering high stereoselectivity and water tolerance for scalable API intermediate manufacturing.
Patent CN114920775B reveals high-selectivity catalyst synthesis. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing processes.
Novel 3-step synthesis of chiral imidazolone NHC precursors from bromoacetyl bromide. Enhances asymmetric catalysis efficiency and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN106866389A reveals copper-catalyzed asymmetric synthesis. Offers high enantioselectivity up to 95% ee for pharmaceutical intermediates.
Patent CN110452150B details a novel chiral phosphoric acid catalyzed synthesis of axial chiral indole-naphthalenes, offering high enantioselectivity and scalable manufacturing for advanced catalytic applications.
Patent CN117820316B reveals a novel chiral phosphoric acid catalyzed route for high-purity indolo compounds with significant cost reduction in API manufacturing and supply chain reliability.
Patent CN110467555B reveals a chiral phosphoric acid catalyzed route for high-purity indole-naphthalene intermediates, offering mild conditions and superior enantioselectivity for scalable API production.
Patent CN112759595B details a novel Pd-catalyzed asymmetric allylation for chiral nucleosides, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles. High yield, mild conditions, scalable for pharma intermediates.
Patent CN114160206B reveals a novel chiral copper catalyst enabling high-yield, enantioselective synthesis of indole pharmaceutical intermediates with superior purity.
Novel organocatalytic route for high-purity axial chiral indole-naphthalenes. Cost-effective, scalable process for asymmetric catalysis intermediates.
Patent CN110452150B discloses a novel organocatalytic route for high-purity axial chiral indole-naphthalenes. This method offers significant cost reduction in chiral catalyst manufacturing and scalable production capabilities.
Novel chiral phosphoric acid catalyzed synthesis offers high optical purity and mild conditions for scalable pharmaceutical intermediate manufacturing and supply chain optimization.
Novel synthesis of axial chiral arylindole compounds via chiral phosphoric acid. High optical purity for pharmaceutical intermediates manufacturing.
Patent CN102766092A details a mild chiral spiro phosphoric acid catalyzed synthesis of optically active tetrahydroquinolines, offering high enantioselectivity and simplified purification for API manufacturing.
Novel quinoline-substituted ligand enables high ee asymmetric trifluoromethylation. Cost-effective synthesis for pharmaceutical intermediate manufacturing supply chain.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method yielding high-purity axially chiral oxindole-substituted styrenes for asymmetric catalysis applications.
Novel axial chiral bisindole catalysts for asymmetric synthesis. Superior stereoselectivity and mild conditions for pharmaceutical intermediates manufacturing.